A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma

References

• Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481–8
   PubMed Web of Science ®Google Scholar
• Flanigan RC, Campbell SC, Clark JI, Picken MM. Metastatic renal cell carcinoma. Curr Treat Options Oncol 2003; 4: 385–90
   PubMedGoogle Scholar
• Escudier B, Szczylik C, Eisen T, Ondard S, Staehler M, Negrier S, et al. Randomized phase III trial of the Raf kinase and VEGFR inhibitor sorafenib (BAY 43-9006) in patients with advanced renal cell carcinoma (RCC). J Clin Oncol (Meeting Abstracts) Late Breaking Abstracts 2005;23: 1093s. Abstracts 4510.
   Google Scholar
• Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, et al. Sutinib in patients with metastatic renal cell carcinoma. JAMA 2006; 295(21)2516–24
   PubMed Web of Science ®Google Scholar
• Cerfolio RJ, Allen MS, Deschamps C, Daly RC, Wallrichs SL, Trastek VF, et al. Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 1994; 57: 339–44
   PubMed Web of Science ®Google Scholar
• Fourquier P, Regnard JF, Rea S, Levi Fand Leuasseur P, et al. Lung metastases of renal cell carcinoma: results of surgical resection. Eur J Cardiothoracic Surg 1997; 11: 17–21
   PubMedGoogle Scholar
• Wronski M, Arbit E, Russo P, Galicich JH. Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology 1996; 47: 187–93
   PubMed Web of Science ®Google Scholar
• Karlsson B, Wersäll P, Lippitz B, Kihlström L. Repeated radiosurgery versus fractionated radiotherapy in the treatment of brain metastases from renal cell car. Radiosurgery, D Kondziolka. Basel, Karger 1999; 232–9
   Google Scholar
• Kihlstrom L, Karlsson B, Lindquist C, Noren G, Rahn T. Gamma knife surgery for cerebral metastasis. Acta Neurochir Suppl (Wien) 1991; 52: 87–98
   PubMedGoogle Scholar
• Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994; 33: 677–83
   PubMed Web of Science ®Google Scholar
• Lax I, Blomgren H, Larson D, Näslund I. Extracranial stereotactic radiosurgery of localized targets. J Radiosurgery 1998; 1: 135–48
   Google Scholar
• Gunven P, Blomgren H, Lax I. Radiosurgery for recurring liver metastases after hepatectomy. Hepatogastroenterology 2003; 50: 1201–4
   PubMedGoogle Scholar
• Schefter T, Gaspar LE, Kavanagh B, Ceronsky N, Feiner A, Stuhr K, et al. Hypofractionated extracranial stereotactic radiotherapy for liver tumours. Int J Radiat Oncol Biol Phys 2003; 57(Suppl 2)S282
   PubMedGoogle Scholar
• Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004; 60: 186–96
   PubMed Web of Science ®Google Scholar
• Wersall PJ, Blomgren H, Lax I, Kalkner KM, Linder C, Lundell G, et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 2005;77:88–95. Epub 2005 Jun 20.
   Google Scholar
• Schwartz LH, Mazumdar M, Wang L, Smith A, Marion S, Panicek DM, et al. Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials. Cancer 2003; 98: 1611–9
   PubMedGoogle Scholar
• Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumours using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995; 34: 861–70
   PubMed Web of Science ®Google Scholar
• Lax I. Target dose versus extratarget dose in stereotactic radiosurgery. Acta Oncol 1993; 32: 453–7
   PubMed Web of Science ®Google Scholar
• Camphausen K, Moses MA, Menard C, Sproull M, Beecken WD, Folkman J, et al. Radiation abscopal antitumor effect is mediated through p53. Cancer Res 2003; 63(8)1990–3
   PubMed Web of Science ®Google Scholar
• Wersäll P, Blomgren, H, Lax I, Pisa P, Svedman C. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. Accepted for publication Acta Oncol 2006.
   Google Scholar